Edition:
India

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

255.05INR
17 May 2019
Change (% chg)

Rs-0.60 (-0.23%)
Prev Close
Rs255.65
Open
Rs254.85
Day's High
Rs257.25
Day's Low
Rs251.20
Volume
177,197
Avg. Vol
337,648
52-wk High
Rs337.80
52-wk Low
Rs180.00

Latest Key Developments (Source: Significant Developments)

India's Suven Life Sciences Dec-Qtr Net Profit Falls
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Suven Life Sciences Ltd ::DEC QUARTER NET PROFIT 252.3 MILLION RUPEES VERSUS PROFIT 346 MILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 1.50 RUPEES PER SHARE.DEC QUARTER REVENUE FROM OPERATIONS 1.29 BILLION RUPEES VERSUS 1.64 BILLION RUPEES YEAR AGO.  Full Article

Suven Life Sciences Gets Product Patents In New Zealand, Norway
Tuesday, 22 May 2018 

May 22 (Reuters) - Suven Life Sciences Ltd ::SAYS CO SECURES PRODUCT PATENTS IN NEW ZEALAND AND NORWAY.SUVEN LIFE SCIENCES SAYS PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS PATENTS ARE VALID THROUGH 2034 AND 2027.  Full Article

Suven Life Sciences Gets Product Patents In Australia, Eurasia And Europe
Wednesday, 9 May 2018 

May 9 (Reuters) - Suven Life Sciences Ltd ::SECURES PRODUCT PATENTS IN AUSTRALIA, EURASIA AND EUROPE.SAYS PATENTS ARE VALID THROUGH 2034.  Full Article

Suven Life Sciences Secures Product Patents In Canada, India
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Suven Life Sciences Ltd ::‍SAYS SECURES PRODUCT PATENTS IN CANADA AND INDIA.SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS CANADA AND INDIA PATENTS ARE VALID THROUGH 2034 AND 2028 ‍​RESPECTIVELY.  Full Article

India's Suven Life Sciences gets product patent in Singapore
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Suven Life Sciences Ltd :Gets product patent from Singapore related to new chemical entities for treating disorders associated with neurodegenerative diseases.  Full Article

India's Suven Life Sciences June-qtr profit falls
Monday, 14 Aug 2017 

Aug 14 (Reuters) - Suven Life Sciences Ltd :June quarter net profit 295.7 million rupees versus 325.8 million rupees year ago.June quarter total revenue from operations 1.41 billion rupees versus 1.33 billion rupees year ago.  Full Article

Suven Life Sciences secures product patent in Australia
Friday, 21 Jul 2017 

July 21 (Reuters) - Suven Life Sciences Ltd :Says Suven Life Sciences secures a product patent in Australia.Suven Life Sciences - patents for new chemical entities for treatment of disorders associated with neurodegenerative diseases.Suven Life Sciences -patents are valid through 2034.  Full Article

Suven Life Sciences secures product patent in Australia and the U.S.
Tuesday, 13 Jun 2017 

June 13 (Reuters) - Suven Life Sciences Ltd :Suven Life Sciences secures a product patent in Australia and USA.Patents corresponding to new chemical entities for treatment of neurodegenerative diseases disorders.Patents are valid through 2032 and 2034.  Full Article